Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 63629-2184

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 63629-2184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 1)

FDA Label Image

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 2)

FDA Label Image

Label (Lbl636292184)

This is a medication label for NILD containing Doxylamine Succinate and Pyridoxine Hydrochloride in a delayed-release tablet form. The label contains warning instructions to keep the medication away from children and protect it from moisture and light. It also warns not to crush, chew, or split the tablets. The medication is available in a film-coated form and must be dispensed in the original container or equivalent air-tight and light-resistant container. The NDC number is 63629-2184-1, and each tablet contains 10mg Doxylamine Succinate and Pyridoxine Hydrochloride.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.